Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective naltrexone-derived opioid receptor antagonists.

A E Takemori1, P S Portoghese

  • 1Department of Pharmacology, University of Minnesota Medical School, Minneapolis 55455.

Annual Review of Pharmacology and Toxicology
|January 1, 1992
PubMed
Summary

Researchers developed selective opioid receptor antagonists from naltrexone. These ligands, like norBNI, NTI, and NTB, target kappa and delta opioid receptors, aiding in pharmacological and physiological studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripherally mediated opioid combination therapy in mouse and pig.

The journal of pain·2024
Same author

Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats.

Vaccine·2012
Same author

An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia.

The Journal of pharmacology and experimental therapeutics·2012
Same author

The FEMA GRAS assessment of aliphatic and aromatic terpene hydrocarbons used as flavor ingredients.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2011
Same author

Transfer of fatty acyl groups from membrane phosphatides to opiate ligands.

Neurochemistry international·2010
Same author

The FEMA GRAS assessment of alpha,beta-unsaturated aldehydes and related substances used as flavor ingredients.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2008

Area of Science:

  • Pharmacology and Medicinal Chemistry
  • Neuroscience
  • Molecular Biology

Background:

  • Opioid receptor research is crucial for understanding pain, addiction, and neurological functions.
  • Selective ligands are essential tools for dissecting the specific roles of different opioid receptor subtypes.
  • Naltrexone serves as a valuable precursor for developing novel opioid receptor modulators.

Purpose of the Study:

  • To design and characterize highly selective opioid receptor antagonists using naltrexone as a chemical scaffold.
  • To investigate the principle of simultaneous occupation of adjacent recognition sites for enhanced ligand selectivity.
  • To provide novel pharmacological tools for studying kappa and delta opioid receptor functions.

Main Methods:

  • Chemical synthesis of naltrexone derivatives.

Related Experiment Videos

  • In vitro and in vivo assays to determine receptor binding affinity and selectivity.
  • Pharmacological characterization of antagonist activity at kappa and delta opioid receptors.

    • Main Results:

    • Successful development of selective kappa opioid receptor antagonist norBNI.
    • Development of selective delta opioid receptor antagonists NTI and NTB.
    • Demonstration that simultaneous occupation of neighboring sites enhances antagonist selectivity.

    Conclusions:

    • Naltrexone-derived antagonists offer a powerful strategy for achieving high opioid receptor subtype selectivity.
    • These selective antagonists (norBNI, NTI, NTB) are valuable tools for opioid research.
    • The developed ligands facilitate the study of kappa and delta opioid receptor roles in various biological processes.